Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Kathleen Viveiros"'
Autor:
Taniris Cafiero Braga, Cristiane J. da-Silva, Leonardo da Silva Neto, José Evaldo Rodrigues De Menezes Filho, Silvia Guatimosim, Itamar Couto Guedes de Jesus, Ângelo de Fátima, Luzia V. Modolo, Paula Rhana, Jader S. Cruz, Kathleen Viveiros Soares
Publikováno v:
New Journal of Chemistry. 45:671-678
A new alleged monastrol-H2S releasing hybrid, named MADTOH, was designed based on the structure of monastrol (M) and 5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione (ADTOH) and synthesized in 7.8% overall yield. MADTOH was shown to be an H2S donor under
Autor:
Kathleen Viveiros
Publikováno v:
Clin Liver Dis (Hoboken)
There are many reasons to promote lifestyle modifications for NAFLD as the first and, perhaps, best therapy (Fig. (Fig.2).2). Clinical trials for NAFLD show that adoption of healthy behaviors is possible in a study environment. Standardization of
Autor:
Nyann Latt, Michael Li, Ponni V. Perumalswami, Marina Roytman, Patricia P. Bloom, Kali Zhou, Kara Wegermann, Nia Adeniji, Paul Y. Kwo, Blanca Lizaola-Mayo, Rotonya M. Carr, Donghee Kim, Winston Dunn, Jose D. Debes, Atoosa Rabiee, Vincent L. Chen, Sonal Kumar, Tzu Hao Lee, Alexander S. Vogel, Walter W. Chan, Veronica Nguyen, David M. Chascsa, Kathleen Viveiros, Andrea D. Branch, Andreea M. Catana, Costica Aloman, Kenneth D. Chavin, Brett Sadowski, Elizabeth S. Aby, Akshata Moghe, Renumathy Dhanasekaran
Publikováno v:
Clinical Gastroenterology and Hepatology
Background & Aims Chronic liver disease (CLD) represents a major global health burden. We undertook this study to identify the factors associated with adverse outcomes in patients with CLD who acquire the novel coronavirus-2019 (COVID-19). Methods We
Autor:
Joyce C. Zhou, Ahmad Najdat Bazarbashi, Walter W. Chan, Lin Shen, Danny Wong, Nikroo Hashemi, Kelly Hathorn, Kathleen Viveiros, Cheikh Njie, Thomas R. McCarty, Walker D. Redd
Publikováno v:
Liver International
Liver injury has been described with COVID‐19, and early reports suggested 2%‐11% of patients had chronic liver disease (CLD). In this multicentre retrospective study, we evaluated hospitalized adults with laboratory‐confirmed COVID‐19 and th
Autor:
Nikroo Hashemi, Trisha Pasricha, Kathleen Viveiros, Patricia P. Bloom, Karin L. Andersson, Daniel S. Pratt, Irun Bhan
Publikováno v:
Digestive Diseases and Sciences
Background Coronavirus disease 2019 (COVID-19) is associated with elevated liver biochemistries in approximately half of hospitalized patients, with many possible etiologies. Aim To assess agreement on the etiology of abnormal liver biochemistries an
Publikováno v:
Clinical Gastroenterology and Hepatology
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sonali Paul, Ethan M Balk, John B. Wong, Akriti Saxena, Aaron Dickstein, Norma Terrin, Kathleen Viveiros
Publikováno v:
Hepatology. 66:379-388
Patients with resolved hepatitis B virus (HBV) infection who are treated for hematological malignancies remain at risk for HBV reactivation. Because of conflicting studies about whether the antibody to hepatitis B surface antigen (anti-HBs) protects
Autor:
Christopher C. Thompson, Lolwa Al Obaid, Kathleen Viveiros, Marvin Ryou, Mohammad Bilal, Ahmad Najdat Bazarbashi
Publikováno v:
Gastrointestinal Endoscopy. 91:AB523-AB524
Autor:
Lin Shen, Cheikh Njie, Ahmad Najdat Bazarbashi, Joyce C. Zhou, Thomas R. McCarty, Kelly Hathorn, Danny Ka-Ho Wong, Kathleen Viveiros, Walker D. Redd, Walter W. Chan, Nikroo Hashemi
Publikováno v:
American Journal of Gastroenterology. 115:S581-S581
INTRODUCTION: Liver injury has been described with COVID-19, and early reports suggested 2-11% of patients had chronic liver disease (CLD) However, there are limited reports on the nature of liver disease among COVID-19 patients and how underlying CL